phase 1_2_completion
saveAbbVie Inc — venetoclax (Phase I/II Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Leukemia, Leukemia, T-Cell Leukemia
Data sources
globaldata
Found something off?
drug timeline · 8
- phase 3 initiationInstitute of Hematology and Blood Diseases Hospital — venetoclax (Phase III Trial Initiation)Apr 29, 2026 · 165d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalFeb 19, 2026 · 234d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalJun 15, 2022 · 1579d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalOct 22, 2021 · 1815d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalOct 4, 2021 · 1833d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalNov 19, 2020 · 2152d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalOct 16, 2020 · 2186d ago
- approvalVENCLEXTA (VENETOCLAX) — FDA approvalOct 16, 2020 · 2186d ago
same company · ±60 days · 6
- phase 1 2 completionblinatumomab: AbbVie Inc — blinatumomab (Phase I/II Trial Completion)Apr 30, 2026
- earningsAbbVie Inc. earningsApr 29, 2026
- grantUNIV OF NORTH CAROLINA CHAPEL HILL — A Trial of Upadacitinib for Non-responsive Eosinophilic esophagitis (ATUNE)Apr 6, 2026
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalMar 31, 2026
related news · 8
- biopharma diveBiotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
- endpointsBeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
- oncliveDr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practice
- oncliveFDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AML
- oncliveFDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
- oncliveDr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AML
- oncliveCombination and Sequencing Strategies in Metastatic Castration-Resistant Prostate Cancer
- oncliveTreatment Sequencing in Metastatic Castration-Resistant Prostate Cancer
🐶 often sniffed alongside
top 7- drugVENCLEXTA82 co-mentions · 22 sources
- tagApproval80 co-mentions · 20 sources
- tagSmall Molecule40 co-mentions · 20 sources
- tagOncology2 co-mentions · 2 sources
- tagHematology2 co-mentions · 1 sources
- companyInstitute of Hematology and Blood Diseases Hospital1 co-mentions · 1 sources
- tagAML1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that